DMB

BNY Mellon Municipal Bond Infrastructure Fund, Inc.

NYSE · CIK 0001565381
$10.90 -0.18%
Vol
Inst. Holders3 funds
Inst. Value$4.0M
Inst. Activity0 buys / 1 sells
Exchange NYSE·CIK 0001565381·Prev Close $10.92

Recent Activity

Inst.
WELLS FARGO & COMPANY/MN — TRIM
32,196 shares ($353.8K)
Inst.
UBS Group AG — TRIM
21,436 shares ($229.4K)

Top Institutional Holders

FundValueMove
MORGAN STANLEY$2.8M
BANK OF AMERICA CORP$821.1K
WELLS FARGO & COMPANY/MN$353.8KTRIM
3 institutional holders with $4.0M total value (360,828 shares) as of 2025-Q4. Top holders: MORGAN, BANK, WELLS. Net selling activity: 1 institutions trimmed/exited vs 0 added.

Top Institutional Holders — 2025-Q4

#FundSharesValue% of TrackedLast Move
1MORGAN STANLEY253,914$2.8M70.4%
2BANK OF AMERICA CORP /DE/74,718$821.1K20.7%
3WELLS FARGO & COMPANY/MN32,196$353.8K8.9%TRIM -39.9%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
WELLS FARGO & COMPANY/MNTRIM53,56132,196-39.9%$353.8K2025-Q4
UBS Group AGTRIM29,50321,436-27.3%$229.4K2025-Q3
WELLS FARGO & COMPANY/MNTRIM94,42767,060-29.0%$685.4K2025-Q2
UBS Group AGADD21,59429,503+36.6%$301.5K2025-Q2

No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.